Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345241 · ClinicalTrials.gov registry record · NA
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
A NA study of Keratoconjunctivitis Sicca, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00345241 is a NA study of Keratoconjunctivitis Sicca that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12 participants, below the 171-participant average among 9 other Keratoconjunctivitis Sicca trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00345241, a NA study of Keratoconjunctivitis Sicca, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate tear film stability of a market lubricant therapeutic eye drop versus saline when using Evaporometry and Interferometry in patients with a diagnosis of Keratoconjunctivitis Sicca (KCS). The purpose of this research is to evaluate evaporative parameters and tear film quality when using Systane lubricating eye drops versus saline in the eyes of dry eye patients at pre-instillation and at 30 and 60 minutes post instillation of drop(s).
Conditions Studied
Interventions
- DRUG Systane Ocular Drops (OTC)
- DRUG Placebo - Saline Drops
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00345241
The ClinicalTrials.gov registry entry for NCT00345241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 171-participant average among 9 other Keratoconjunctivitis Sicca trials with a reported enrollment target (93% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keratoconjunctivitis Sicca appearing as the primary indexed condition, and to 2 interventions - of which Systane Ocular Drops (OTC) is the first listed.
NCT00345241 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00345241 about?
NCT00345241 is a clinical study titled "Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points". To evaluate tear film stability of a market lubricant therapeutic eye drop versus saline when using Evaporometry and Interferometry in patients with a diagnosis of Keratoconjunctivitis Sicca (KCS). The purpose of this research is to evaluate evaporative parameters and tear film quality when using Sy...
What is the current status of trial NCT00345241?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-01. Estimated completion is 2006-12.
What conditions does trial NCT00345241 study?
This clinical trial studies the following conditions: Keratoconjunctivitis Sicca.
What interventions are being tested in trial NCT00345241?
The interventions under investigation include: Systane Ocular Drops (OTC) (DRUG), Placebo - Saline Drops (DRUG).
Who is sponsoring clinical trial NCT00345241?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00345241 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconjunctivitis Sicca
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
COMPLETED · NA
-
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
COMPLETED
-
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
COMPLETED · Phase 3
-
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
COMPLETED · Phase 2
-
Effects of Dry Eye Treatments on the Ocular Surface
COMPLETED · Phase 4
-
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.